These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9222274)

  • 1. Managing the late complications of Parkinson's disease.
    Waters CH
    Neurology; 1997 Jul; 49(1 Suppl 1):S49-57. PubMed ID: 9222274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced stage patients with Parkinson's disease.
    Waters CH
    Parkinsonism Relat Disord; 2002 Oct; 9(1):15-21. PubMed ID: 12217618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management for motor and non-motor complications in late Parkinson's disease.
    Chan DK; Cordato DJ; O'Rourke F
    Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing late complications of Parkinson's disease.
    Stacy M
    Med Clin North Am; 1999 Mar; 83(2):469-81, vii. PubMed ID: 10093588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and management of neuropsychiatric complications in Parkinson's disease.
    Ferreri F; Agbokou C; Gauthier S
    CMAJ; 2006 Dec; 175(12):1545-52. PubMed ID: 17146092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problem based review: a patient with Parkinson's disease.
    Arora A; Fletcher P
    Acute Med; 2013; 12(4):246-50. PubMed ID: 24364059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.
    Simonson W; Hauser RA; Schapira AH
    Ann Pharmacother; 2007 Nov; 41(11):1842-9. PubMed ID: 17878397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatments for the neuropsychiatric complications of Parkinson's disease.
    Connolly BS; Fox SH
    Expert Rev Neurother; 2012 Dec; 12(12):1439-49. PubMed ID: 23237351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D; Hanssens Y; Northway MG
    Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Băjenaru O; Ene A; Popescu BO; Szász JA; Sabău M; Mureşan DF; Perju-Dumbrava L; Popescu CD; Constantinescu A; Buraga I; Simu M
    J Neural Transm (Vienna); 2016 Apr; 123(4):407-14. PubMed ID: 26699635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
    Moreau C; Delval A; Defebvre L; Dujardin K; Duhamel A; Petyt G; Vuillaume I; Corvol JC; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Sablonniere B; Azulay JP; Tison F; Rascol O; Vidailhet M; Destée A; Bloem BR; Bordet R; Devos D;
    Lancet Neurol; 2012 Jul; 11(7):589-96. PubMed ID: 22658702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE.
    Cattaneo C; Sardina M; Bonizzoni E
    J Parkinsons Dis; 2016; 6(1):165-73. PubMed ID: 26889632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor complications of Parkinson's disease.
    Martignoni E; Riboldazzi G; Calandrella D; Riva N
    Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
    Pahwa R
    J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.
    Amboni M; Stocchi F; Abbruzzese G; Morgante L; Onofrj M; Ruggieri S; Tinazzi M; Zappia M; Attar M; Colombo D; Simoni L; Ori A; Barone P; Antonini A;
    Parkinsonism Relat Disord; 2015 Jun; 21(6):644-9. PubMed ID: 25899545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of late stage complications in Parkinson's disease.
    Stoessl AJ
    Can J Neurol Sci; 1992 Feb; 19(1 Suppl):113-6. PubMed ID: 1571855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.